StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Third-Party Personnel LTIR by Year

Third-Party Personnel LTIR (×)

Novartis Third-Party Personnel LTIR: 0.32× in FY2025, up 6.7% from a year earlier.

Latest, FY2025
0.32
Period ended Dec 31, 2025
Change on a year earlier
+6.7%
0.30 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf

Where the FY2025 figure comes from

“| Third-party personnel | 0.32 | 0.30 | ∆ | 25 |”

Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Reported in ESG Data Summary 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Novartis Third-Party Personnel LTIR (×), annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/hse-ltir-thirdparty

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.